NCT05451433

The Effect of Saccharomyces Boulardii in Clinical Presentation and Quality of Life Patient With IBS

• Status: Unknown
• Phase: N/A
• Study type: Interventional
• Enrollment: 52 (estimated)
• Sponsor: Fakultas Kedokteran Universitas Indonesia · Academic / Other
• Sex: All
• Age: 18 Years
• Healthy volunteers: Accepted

Summary

This study aims to compare the effectiveness of Saccharomyces Boulardii vs Placebo in patient with Irritable Bowel Syndrome

Detailed description

This study aims to compare the effectiveness of Saccharomyces Boulardii vs Placebo in patient with Irritable Bowel Syndrome within timeframe of study 28 days and then will be examined the outcome as the improvement quality of life

Conditions

• Irritable Bowel Syndrome

Interventions

Type	Name	Description
DRUG	Saccharomyces Boulardii 250 MG	Normagut capsule twice a day
DRUG	Placebo	Placebo capsule twice a day

Timeline

• Start date: 2022-08-01
• Primary completion: 2022-08-01
• Completion: 2022-12-01
• First posted: 2022-07-11
• Last updated: 2022-07-20